Dr. Essam Hamza reports

ROCKET DOCTOR PARTNERS WITH MELANOMA CANADA TO EXPAND ACCESS TO FOLLOW-UP CARE FOR AT-RISK PATIENTS

Treatment.com AI Inc.'s virtual care subsidiary, Rocket Doctor Inc., has partnered with Melanoma Canada to help bridge the care gap for individuals identified as at risk for melanoma and other skin cancers during mobile screening events across the country.

Highlights:

• Rocket Doctor has partnered with Melanoma Canada to provide timely follow-up care for patients identified as at-risk during mobile skin cancer screenings.
• Patients without a family doctor will be directly referred to physicians on Rocket Doctor through a streamlined digital intake process.
• The Mole Mobile campaign travels across Alberta, British Columbia, Ontario and Quebec, providing free screenings in both remote and urban communities.
• Skin cancer is the most common cancer in Canada, with one in three cancer diagnoses being skin related -- more than breast, prostate, lung and colon cancers combined.
• Twenty-two Canadians are diagnosed with melanoma every day, and three Canadians die daily from this serious form of skin cancer.
• The partnership is expected to increase patient visits on Rocket Doctor's platform, improving access to care and continuity for at-risk individuals.

Melanoma Canada's Mole Mobile units, Canada's first mobile skin cancer screening clinics, presented by Neutrogena, a Kenvue brand, travel across Alberta, British Columbia, Ontario and Quebec, offering free skin checks from certified dermatologists in both remote and urban communities. Through this partnership, Rocket Doctor will provide patients who do not have a family physician with timely access to follow-up appointments through its virtual care platform.

"Too many Canadians are going without the care they need simply because they don't have a family doctor," said Dr. William Cherniak, founder and chief executive officer of Rocket Doctor. "By partnering with Melanoma Canada, we're making it easier for patients identified during these critical screenings to get connected to a physician quickly, ensuring no one falls through the cracks."

Dermatologists working in the Mole Mobile units will complete an on-site risk assessment and referral form for patients who require follow-up. These forms can then be uploaded directly to Rocket Doctor's intake system, enabling efficient, streamlined review and timely access to appropriate care.

The need for follow-up care has never been more urgent. Skin cancer is the most commonly diagnosed cancer in Canada, more prevalent than breast, prostate, lung and colon cancers combined. One in every three cancers diagnosed in Canada is a skin cancer, and the incidence of melanoma, the deadliest form, continues to rise. Every day, 22 Canadians are diagnosed with melanoma, and three die from it.

"With one in three cancers diagnosed in Canada being skin cancer, access to timely follow-up care is crucial," said Falyn Katz, chief executive officer of Melanoma Canada. "Our partnership with Rocket Doctor ensures that individuals flagged during our screenings, many of whom don't have a family doctor, can seamlessly transition from screening to care. It's a powerful step forward in improving outcomes for patients who might otherwise be left waiting."

The initiative is expected to increase patient traffic across Rocket Doctor's platform during Mole Mobile's national tour while reinforcing Rocket Doctor's mission to improve equitable access to physician-led care. As part of the collaboration, Rocket Doctor's logo will also appear on Mole Mobile vans and campaign materials, which collectively generate millions of impressions throughout the tour. The term of this agreement is 12 months commencing Feb. 3, 2025, and will automatically renew for successive 12-month periods unless either party provides at least 30 days of written notice of termination prior to the renewal date.

Initial events will kick off in Toronto and Edmonton this spring, with additional stops planned through October, 2025.

About Rocket Doctor Inc.

Rocket Doctor is a technology-driven digital health platform and marketplace that empowers doctors to build and manage their own virtual or hybrid practices. Its proprietary software and artificial-intelligence-powered tools enable providers to deliver high-quality care remotely, with a focus on reaching underserved and remote communities across North America. By removing barriers to care and restoring physician autonomy, Rocket Doctor is redefining what modern health care looks like.

About Treatment.com AI Inc.

Treatment.com AI is a company utilizing AI and best clinical practices to positively improve the health care sector and impact current inefficiencies and challenges. With the input of hundreds of health care professionals globally, Treatment.com AI has built a comprehensive, personalized health care AI engine -- the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all health care professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps health care professionals (doctors, nurses or pharmacists) reduce their administrative burden, creates more time for needed face-to-face patient appointments and enables greater consistency in quality of patient support. Treatment.com AI's GLM platform, through supporting health care professionals, allows for the inclusion of disenfranchised communities.

We seek Safe Harbor.